Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 300 points on Wednesday.

Shares of Sarepta Therapeutics, Inc. SRPT fell sharply in today's pre-market trading after the company reported a first-quarter adjusted EPS miss.

Therapeutics reported quarterly losses of $3.42 per share, which missed the analyst consensus estimate of losses of 95 cents. Quarterly revenue came in at $744.86 million, which beat the consensus estimate of $683.36 million.

Sarepta Therapeutics lowered its fiscal 2025 revenue to a new range of $2.3 billion to $2.6 billion.

Sarepta Therapeutics shares tumbled 20.6% to $37.10 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

Vestis Corporation VSTS fell 25.7% to $6.47 in pre-market trading after the company reported worse-than-expected quarterly financial results.
Upstart Holdings, Inc. UPST fell 16.2% to $43.09 in pre-market trading after the company issued second-quarter sales guidance below estimates.
Apellis Pharmaceuticals, Inc. APLS dipped 13.6% to $16.53 in pre-market trading following first-quarter results.
Revolve Group, Inc. RVLV fell 10.8% to $16.90 in today's pre-market trading after the company reported downbeat quarterly sales.
The Hackett Group, Inc. HCKT dipped 8.9% to $23.69 in pre-market trading after the company issued weak outlook for the second quarter.
RXO, Inc. RXO fell 7.6% to $12.70 in pre-market trading.
Marvell Technology, Inc. MRVL dipped 7% to $56.94 in pre-market trading after the company postponed its Investor Day amid uncertainty.
Lantheus Holdings, Inc. LNTH declined 6.5% to $98.06 in pre-market trading after the company posted downbeat first-quarter results and lowered its FY25 forecast.
Mercury Systems, Inc. MRCY fell 5.7% to $47.54 in pre-market trading following weaker-than-expected quarterly earnings.
Arista Networks Inc ANET dipped 5.3% to $86.00 in pre-market trading following downbeat quarterly sales.